Advanced Renal Cell Carcinoma Recruiting Phase 2 Trials for Telaglenastat (DB15232)

Also known as: Advanced Renal cell carcinoma

IndicationStatusPhase
DBCOND0032596 (Advanced Renal Cell Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs